GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Woojung Bio Inc (XKRX:215380) » Definitions » Debt-to-Revenue

Woojung Bio (XKRX:215380) Debt-to-Revenue : 1.07 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Woojung Bio Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Woojung Bio's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩20,437 Mil. Woojung Bio's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩30,547 Mil. Woojung Bio's annualized Revenue for the quarter that ended in Dec. 2024 was ₩47,871 Mil. Woojung Bio's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 was 1.07.


Woojung Bio Debt-to-Revenue Historical Data

The historical data trend for Woojung Bio's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Woojung Bio Debt-to-Revenue Chart

Woojung Bio Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.68 1.25 0.87 1.36 1.18

Woojung Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.73 1.29 1.05 1.34 1.07

Competitive Comparison of Woojung Bio's Debt-to-Revenue

For the Biotechnology subindustry, Woojung Bio's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Woojung Bio's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Woojung Bio's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Woojung Bio's Debt-to-Revenue falls into.


;
;

Woojung Bio Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Woojung Bio's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(20437.38 + 30547.329) / 43199.733
=1.18

Woojung Bio's annualized Debt-to-Revenue for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(20437.38 + 30547.329) / 47870.664
=1.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2024) Revenue data.


Woojung Bio Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Woojung Bio's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Woojung Bio Business Description

Traded in Other Exchanges
N/A
Address
Gwanggyo-ro 145, B-dong 3rd Floor, Next Generation Convergence Technology Research Center, Gyeonggi-do, Yeongtong-gu, Suwon-si, KOR
Woojung Bio Inc is engaged in the research and development of natural science and engineering. Its products include Gene Delivery, Antibody Production, Immunodeficiency model, Human-to-human model, Zika, Mers, Dengue, Influenza Virus Research, Influenza virus, vaccine studies, and Elegant Goettingen Mini Pig.

Woojung Bio Headlines

No Headlines